Exousia Bio, Inc. (LMMY) Operating cash flow 2023–2025
Exousia Bio, Inc. (LMMY) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$4,528FY2025 · since FY2023: -$38,111 → -$4,528
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$4,528 | +63.7% |
| FY2024 | -$12,484 | +67.2% |
| FY2023 | -$38,111 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LMMY financial trends
LMMY RevenueLMMY Net incomeLMMY Net marginLMMY Gross profitLMMY Gross marginLMMY Operating incomeLMMY Operating marginLMMY Free cash flowLMMY Capital expendituresLMMY Return on equityLMMY Stock buybacksLMMY Dividends paidLMMY Total assetsLMMY Total liabilitiesLMMY Shareholders’ equityLMMY overview →